Capsule sponge test to find esophagus cancer early
Part of Cancer, Digestive system clinical trials.
This trial tests a capsule sponge device to spot esophageal cancer in people at high risk, including those with past head or neck cancer or newly diagnosed esophageal cancer. The goal is to see if the capsule sponge can catch cancer early without needing a traditional endoscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- For people with newly diagnosed esophageal squamous cell cancer (a type of throat cancer) or those getting radiation or chemo for it.
- For people who had treatment for head or neck cancer at least 12 months ago.
- For people who had endoscopic treatment for early esophageal cancer at least 6 months ago.
- You can swallow mixed foods and tablets (no severe trouble swallowing).
- You agree to provide tissue samples for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies an “EsophaCap” capsule that can be swallowed during an endoscopy to help detect early esophageal cancer. It may help find cancer earlier and guide next steps, if your results are concerning.
This trial tests whether a personalized treatment plan, chosen using a lab-grown model of your tumor, works better than standard therapy for esophageal cancer that can be surgically removed. It aims to find the most effective drugs for you before surgery.
This study checks whether a swallowable capsule can help find signs of Barrett’s esophagus or esophageal cancer (or related risk) before or around an endoscopy. The goal is to see if this less invasive sampling method could improve screening.
This study checks whether a special sponge you swallow (EsophaCap) can help detect early esophageal cancer—or help sort out concerning symptoms. You may be contacted again 1–2 weeks later for a short interview.
This study tests a new, less invasive way to collect cells from the esophagus using a small sponge on a string (called Cytosponge). It aims to see if this method can accurately detect Barrett's esophagus, a condition that can raise the risk of esophageal cancer.
This study tests minimally invasive, sample-based tests during an endoscopy to find Barrett’s esophagus and help sort it from esophageal cancer risk. It may help doctors spot changes earlier and more accurately using less invasive methods than standard tissue testing alone.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.